Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing (Q38177684)

30 August 2017

title

Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing (English)

1 reference

30 August 2017

0 references

Genevieve E Martin

2

0 references

Reena Rajasuriar

object named as

Reena Rajasuriar

series ordinal

3

0 references

author name string

Anna C Hearps

series ordinal

1

1 reference

30 August 2017

Suzanne M Crowe

series ordinal

4

1 reference

30 August 2017

language of work or name

1 reference

1 March 2014

1 reference

30 August 2017

published in

Current HIV/AIDS reports

1 reference

30 August 2017

volume

11

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

20-34

1 reference

Systemic effects of inflammation on health during chronic HIV infection

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Neopterin as a marker for immune system activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

No association of abacavir use with myocardial infarction: findings of an FDA meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Inflammation, coagulation and cardiovascular disease in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Arterial inflammation in patients with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

The macrophage: the intersection between HIV infection and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Impaired functions of peripheral blood monocyte subpopulations in aged humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

High prevalence of radiological vertebral fractures in HIV-infected males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

HIV: inflammation and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Association between bone mineral density and C-reactive protein in a large population-based sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

High-sensitivity CRP is an independent risk factor for all fractures and vertebral fractures in elderly men: the MrOS Sweden study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Mechanisms of impaired bone strength in type 1 and 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Association between chronic hepatitis C virus infection and bone mineral density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Bone, fracture and frailty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Association between peripheral T-Lymphocyte activation and impaired bone mineral density in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Microbial translocation in the pathogenesis of HIV infection and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Plasma levels of soluble CD14 independently predict mortality in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Long-term suppressive combined antiretroviral treatment does not normalize the serum level of soluble CD14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Relationship between microbial translocation and endothelial function in HIV infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Microbial translocation in HIV infection is associated with dyslipidemia, insulin resistance, and risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Markers of microbial translocation predict hypertension in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Detection of microbial translocation in HIV and SIV infection using the Limulus amebocyte lysate assay is masked by serum and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Telomeres and cardiovascular disease risk: an update 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Telomere shortening in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Leukocyte telomere length is associated with noninvasively measured age-related disease: The Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

The role of CD8+ T-cell replicative senescence in human aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Telomerase activity in peripheral blood mononuclear cells from HIV and HIV-HCV coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Telomerase inhibition may contribute to accelerated mitochondrial aging induced by anti-retroviral HIV treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Molecular mechanisms involved in HIV-1-Tat mediated inhibition of telomerase activity in human CD4(+) T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Reversible senescence in human CD4+CD45RA+CD27- memory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

CMV and Immunosenescence: from basics to clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Virologic correlates of anti-CMV IgG levels in HIV-1-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Senescent cells as a source of inflammatory factors for tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Immunosenescence and HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

T cell activation predicts carotid artery stiffness among HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Incidence of Malignancies in HIV‐Infected Patients and Prognostic Role of Current CD4 Cell Count: Evidence from a Large Italian Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Frailty among HIV-infected persons in an urban outpatient care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Frailty in HIV-infected adults in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Low CD4 count is associated with an increased risk of fragility fracture in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Premature age-related comorbidities among HIV-infected persons compared with the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Hypertension and obesity in adults living in a high HIV prevalence rural area in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

High prevalence of obesity among women who enrolled in HIV prevention trials in KwaZulu-Natal, South Africa: healthy diet and life style messages should be integrated into HIV prevention programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Factors associated with prevalence, awareness, treatment and control of hypertension in urban adults from 33 communities in China: the CHPSNE Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

New insights on diabetes mellitus and obesity in Africa-part 1: prevalence, pathogenesis and comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Noncommunicable diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

China's biggest, most neglected health challenge: Non-communicable diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Bone mass, body composition and vitamin D status of ARV-naïve, urban, black South African women with HIV infection, stratified by CD₄ count.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Cardiovascular risk factors in adult Malawians on long-term antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Increased carotid intima-media thickness associated with antibody responses to varicella-zoster virus and cytomegalovirus in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Improving responsiveness of health systems to non-communicable diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

The end of AIDS: HIV infection as a chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Statin therapy and mortality in HIV-infected individuals; a Danish nationwide population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Reduction of immune activation with chloroquine therapy during chronic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Inflammation and sudden cardiac death in a community-based population of older adults: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Elevated D-dimer is independently associated with endothelial dysfunction: a cross-sectional study in HIV-infected adults on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Plasma monocyte chemoattractant protein-1 and tumor necrosis factor-α levels predict the presence of coronary artery calcium in HIV-infected individuals independent of traditional cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Association of C-reactive protein with cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Inflammatory proteins in plasma and the risk of dementia: the rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Markers of microbial translocation and risk of AIDS-related lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Serum IL-6 level and the development of disability in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

C-Reactive Protein, Interleukin 6, Fibrinogen and Risk of Sudden Death in European Middle-Aged Men: The PRIME Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Dual Modulation of Osteoclast Differentiation by Lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Soluble CD163: a biomarker linking macrophages and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

A High Plasma Concentration of TNF- Is Associated With Dementia in Centenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0190-8

Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis.

21 January 2018

1 reference

12 December 2020

Rising Burden of Obesity in Asia

1 reference

12 December 2020

Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques.

1 reference

12 December 2020

Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause.

1 reference

12 December 2020

Modulatory effects of sCD14 and LBP on LPS-host cell interactions

1 reference

12 December 2020

Endotoxemia: methods of detection and clinical correlates

1 reference

12 December 2020

Downregulation of CD38 activation markers by atorvastatin in HIV patients with undetectable viral load

1 reference

12 December 2020

Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study.

1 reference

12 December 2020

Low-level HIV viremia is associated with microbial translocation and inflammation

1 reference

12 December 2020

The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis

1 reference

12 December 2020

Phenotypic characterisation of pro-inflammatory monocytes and dendritic cells in peripheral arterial disease

1 reference

12 December 2020

Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection

1 reference

12 December 2020

The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss

1 reference

12 December 2020

Different biological significance of sCD14 and LPS in HIV-infection: Importance of the immunovirology stage and association with HIV-disease progression markers

1 reference

12 December 2020

Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection

1 reference

12 December 2020

Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis

1 reference

12 December 2020

CD8+ Hyperactivation and Senescence Correlate With Early Carotid Intima-Media Thickness in HIV+ Patients With No Cardiovascular Disease

1 reference

12 December 2020

Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes

1 reference

12 December 2020

Short telomere length, myocardial infarction, ischemic heart disease, and early death

1 reference

12 December 2020

Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors.

1 reference

12 December 2020

Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic

1 reference

12 December 2020

Dendritic cells: unique leukocyte populations which control the primary immune response

1 reference

12 December 2020

CD163 and its role in inflammation

1 reference

12 December 2020

Serum Soluble CD163 Predicts Risk of Type 2 Diabetes in the General Population

1 reference

12 December 2020

Human blood monocytes, but not alveolar macrophages, reveal increased CD11b/CD18 expression and adhesion properties upon receptor-dependent activation

1 reference

12 December 2020

Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial

1 reference

12 December 2020

Leukocyte telomere length and cardiovascular disease in the cardiovascular health study

1 reference

12 December 2020

HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy

1 reference

12 December 2020

Evaluation of selected bone metabolism markers in rheumatoid arthritis patients

1 reference

12 December 2020

10.1007/S11904-013-0190-8

Identifiers

DOI

1 reference

30 August 2017

1 reference